Genomatica, officially known as Genomatica, Inc., is a pioneering biotechnology company headquartered in the United States. Founded in 2000, the company has established itself as a leader in the sustainable chemicals industry, focusing on the development of bio-based processes for producing essential chemicals and materials. With a strong operational presence in North America and Europe, Genomatica is committed to transforming traditional manufacturing through innovative, environmentally friendly solutions. The company’s core offerings include bio-based butanediol (BDO) and other key intermediates, which are produced using proprietary fermentation technology. This unique approach not only reduces reliance on fossil fuels but also lowers greenhouse gas emissions, positioning Genomatica as a frontrunner in the shift towards sustainable production. Notable achievements include strategic partnerships with major industry players, solidifying its market position as a catalyst for change in the chemical sector.
How does Genomatica's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Genomatica's score of 18 is lower than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Genomatica, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Genomatica may still be in the early stages of formalising its climate commitments or reporting practices. As the company operates within the biotechnology sector, it is essential for Genomatica to establish clear climate goals and emissions reduction strategies to align with industry standards and expectations. The absence of emissions data and reduction initiatives may limit its ability to demonstrate leadership in sustainability and climate action.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Genomatica has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

